Skandinaviska Enskilda Banken Ab (Publ) Biogen Inc. Transaction History

Skandinaviska Enskilda Banken Ab (Publ)

$20.7 Billion
Q2 2024

A detailed history of Skandinaviska Enskilda Banken Ab (Publ) transactions in Biogen Inc. stock. As of the latest transaction made, Skandinaviska Enskilda Banken Ab (Publ) holds 83,025 shares of BIIB stock, worth $14.4 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

83,025

Previous 85,595 3.0%

Holding current value

$14.4 Million

Previous $18.5 Million 4.28%

% of portfolio

0.09%

Previous 0.09%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$190.52 - $236.72 $489,636 - $608,370	-2,570 Reduced 3.0%	83,025 $19.2 Million
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $21,202 - $26,770	-100 Reduced 0.12%	85,595 $18.5 Million
Q4 2023 Feb 14, 2024	BUY	$222.59 - $267.94 $381,519 - $459,249	1,714 Added 2.04%	85,695 $22.2 Million
Q3 2023 Nov 09, 2023	SELL	$253.3 - $285.89 $1.14 Million - $1.29 Million	-4,520 Reduced 5.11%	83,981 $21.6 Million
Q2 2023 Aug 07, 2023	BUY	$275.25 - $318.06 $2.18 Million - $2.52 Million	7,927 Added 9.84%	88,501 $25.2 Million
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $381,761 - $435,001	-1,488 Reduced 1.81%	80,574 $22.4 Million
Q4 2022 Feb 08, 2023	SELL	$252.44 - $306.72 $1.3 Million - $1.58 Million	-5,148 Reduced 5.9%	82,062 $22.7 Million
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $1.5 Million - $2.07 Million	-7,703 Reduced 8.12%	87,210 $23.3 Million
Q2 2022 Aug 10, 2022	BUY	$187.54 - $223.02 $1.33 Million - $1.58 Million	7,091 Added 8.07%	94,913 $19.4 Million
Q1 2022 May 11, 2022	SELL	$193.77 - $244.14 $2.53 Million - $3.19 Million	-13,077 Reduced 12.96%	87,822 $18.5 Million
Q4 2021 Feb 10, 2022	SELL	$223.92 - $287.77 $4.67 Million - $6 Million	-20,850 Reduced 17.13%	100,899 $24.2 Million
Q3 2021 Nov 10, 2021	SELL	$282.99 - $369.05 $19.6 Million - $25.6 Million	-69,298 Reduced 36.27%	121,749 $34.4 Million
Q2 2021 Aug 10, 2021	BUY	$259.0 - $414.71 $11.9 Million - $19.1 Million	46,045 Added 31.75%	191,047 $66.2 Million
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $40.3 Million - $47.2 Million	-165,906 Reduced 53.36%	145,002 $40.6 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $4.19 Million - $6.31 Million	-17,748 Reduced 5.4%	310,908 $76.1 Million
Q3 2020 Nov 12, 2020	BUY	$264.77 - $305.71 $2.8 Million - $3.23 Million	10,563 Added 3.32%	328,656 $93.2 Million
Q2 2020 Aug 13, 2020	BUY	$258.66 - $342.55 $2.5 Million - $3.31 Million	9,668 Added 3.13%	318,093 $85.1 Million
Q1 2020 May 13, 2020	SELL	$268.85 - $341.04 $15.4 Million - $19.5 Million	-57,202 Reduced 15.64%	308,425 $97.6 Million
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $19.7 Million - $27.3 Million	-89,662 Reduced 19.69%	365,627 $108 Million
Q3 2019 Nov 08, 2019	BUY	$217.44 - $243.88 $18.7 Million - $21 Million	86,230 Added 23.36%	455,289 $106 Million
Q2 2019 Aug 09, 2019	BUY	$219.29 - $241.72 $16.6 Million - $18.3 Million	75,661 Added 25.79%	369,059 $86.3 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $7.44 Million - $11.6 Million	34,333 Added 13.25%	293,398 $69.4 Million
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $2.43 Million - $3.07 Million	-8,710 Reduced 3.25%	259,065 $78 Million
Q3 2018 Nov 05, 2018	BUY	$293.51 - $383.83 $7.07 Million - $9.25 Million	24,097 Added 9.89%	267,775 $94.6 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $4.41 Million - $5.25 Million	-17,114 Reduced 6.56%	243,678 $70.7 Million
Q1 2018 Apr 30, 2018	SELL	$260.13 - $367.91 $860,249 - $1.22 Million	-3,307 Reduced 1.25%	260,792 $71.4 Million
Q4 2017 Feb 12, 2018	BUY	$307.64 - $344.58 $20.2 Million - $22.6 Million	65,693 Added 33.11%	264,099 $84.1 Million
Q3 2017 Nov 13, 2017	BUY	$281.15 - $329.69 $196,804 - $230,783	700 Added 0.35%	198,406 $62.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	197,706	197,706 $0

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Skandinaviska Enskilda Banken Ab (Publ), based on Form 13F filings with the SEC.

News

Stay updated on Skandinaviska Enskilda Banken Ab (Publ) with notifications on news.

Account

Skandinaviska Enskilda Banken Ab (Publ) Biogen Inc. Transaction History